The safety and protection of USFK remains our number one priority.

Based on the joint recommendation of the U.S. FDA and CDC to end the temporary pause of the Johnson & Johnson COVID-19 vaccine for all persons 18 years and up, and with DOD authorization, USFK will resume offering the J&J vaccine to our eligible population beginning Friday, April 30.

USFK will strictly follow DOD guidance and inform all recipients on the numerous benefits to receiving the Johnson & Johnson vaccine, while also advising of the rare risks of blood clots and low levels of platelets associated with the J&J vaccine.

If you are a female aged 18 - 50 years, and concerned about receiving the J&J vaccine, you may elect to receive the Moderna COVID-19 vaccine instead of the J&J vaccine; please see the USFK website or consult with your medical provider for additional information regarding the differences between the Moderna and J&J vaccines.

For everyone else, please see your or your sponsor's chain of command or supervisor, or follow USFK, 8A or 7AF official social media platforms for additional information on those who want to receive the vaccine, when it will be offered per age bracket and how to schedule an appointment.

While the vaccine remains voluntary, USFK strongly encourages everyone to get vaccinated to help protect the force and our mission.

For more information about the Johnson & Johnson or Janssen COVID-19 Vaccine, view/download the Janssen COVID-19 Fact Sheet or visit the CDC's Janssen COVID-19 Vaccine's page. 

_{Updated as of April 29, 2021.}